Pilot anxiety assessment: how AMEs evaluate stress episodes
An isolated anxiety episode or an acute stress reaction does not, by itself, end medical certification. The EASA framework draws a clear line between a transient adjustment reaction and a clinical disorder. A pilot anxiety assessment follows a structured path: episode type, severity, duration, triggers, treatment and impact on flight safety.
For the broader framework of chronic conditions and pilot medical certificates and for the limitations that may appear on a certificate, read the dedicated articles. This one focuses strictly on the assessment of anxiety and stress episodes.
Diagram of three outcomes in a pilot anxiety assessment: fit, fit with limitation, temporarily unfit
Regulatory framework for pilot anxiety assessment
The aeromedical examiner (AME) works at three regulatory levels. The first is Regulation (EU) 1178/2011, Part-MED, especially MED.B.055 (psychiatric conditions) and MED.B.060 (psychology). The second is the Acceptable Means of Compliance and Guidance Material (AMC/GM) issued by EASA for these articles. The third is the UK CAA Mental Health Guidance Material, widely used across Europe as an operational reference.
Under AMC1 MED.B.055, pilot anxiety assessment is part of the Comprehensive Mental Health Assessment performed at initial Class 1 examination and at renewals. It covers general attitudes towards mental health, coping strategies, recent stressors, family history and the possible presence of personality disorders.
The Comprehensive Mental Health Assessment is not an extended psychometric test battery but a structured interview run by the AME, typically 20-30 minutes long. The AME looks for four risk patterns: positive psychiatric family history, recent episode of affective or anxiety disorder, use of psychoactive substances and prolonged exposure to operational stress. Any of these patterns can trigger a specialist evaluation request.
In Romania the AME is an accredited certified examiner, and final certification decisions, including any limitations, are issued by the Romanian aeromedical authority (the former AACR), now operating as the national licensing authority for aircrew medical certificates. Complex cases (relapses, comorbidities, SSRI treatment) are escalated to the medical assessor of the licensing authority, who confirms or adjusts the AME decision.
Distinguishing acute stress reaction from an anxiety disorder
AMEs use three clinical categories. Acute stress reaction lasts less than 4 weeks and has a clear trigger. Adjustment disorder lasts 4 weeks to 6 months. An anxiety disorder proper (generalised anxiety, panic disorder, specific phobia, agoraphobia) is a stand-alone diagnosis. The category determines the pilot anxiety assessment pathway.
Acute stress reaction: certification possible right after the trigger is resolved. No specialist report required if symptoms have fully remitted and baseline functioning is restored.
Adjustment disorder: needs a structured psychological assessment. The AME may request a report from a clinical psychologist accredited in aviation psychology.
Diagnosed anxiety disorder: psychiatric evaluation is mandatory. The psychiatrist report must include the ICD-10 diagnosis, severity, current treatment, prognosis and a flight-safety risk recommendation.
Panic attacks and the pilot anxiety assessment protocol
An isolated panic attack without a diagnosis of panic disorder is treated as a one-off event. Two elements are critical: an identifiable trigger and absence of loss of consciousness or motor control. Under these conditions, after a 48-hour ground trial and a favourable AME assessment, the pilot may return to duty with monitoring.
Diagnosed panic disorder — recurrent unprovoked attacks — leads to temporary unfit status until pharmacological stabilisation (at least 6-12 attack-free months on treatment) and a favourable psychiatric report. Re-entry usually carries an Operational Multi-pilot Limitation (OML) for Class 1.
Minimum documentation for a pilot anxiety assessment with panic attacks: psychiatric report with full history, validated scale scores (GAD-7, PHQ-9), medication list, monitoring plan.
SSRIs approved for certification: sertraline, citalopram, escitalopram, fluoxetine. Combinations, tricyclics and benzodiazepines remain incompatible with active duty.
Ongoing treatment and certificate impact
EASA has progressively aligned its SSRI certification regime with UK CAA and FAA practice. Four substances are accepted for the pilot with a stabilised anxiety or depressive disorder: sertraline, citalopram, escitalopram, fluoxetine. Treatment must be stable for at least 4 weeks before the recertification assessment, with no significant side effects and no recent dose adjustment.
In practice, a pilot on SSRI receives conditional Class 1 certification with an OML. For Class 2 and LAPL, the equivalent limitation is OSL (Operational Safety Pilot Limitation), which requires a second qualified pilot on board. Re-assessment is yearly, with an updated psychiatric report.
Benzodiazepines (alprazolam, diazepam, lorazepam) remain incompatible with flight duty, even at low doses or occasional use. Wash-out time after last dose: at least 5 half-lives.
Psychotherapy (CBT, EMDR) is compatible with active duty and is often recommended as first-line treatment for mild to moderate anxiety, with no certificate impact.
Comparative table for pilot anxiety assessment: episode type, certificate impact, unfit period
Three practical tips for a successful pilot anxiety assessment
Book the AME appointment at least 45 days before certificate expiry. If you intend to discuss a recent anxiety episode, this margin removes time pressure from the documentation work.
Bring a written timeline of the episode: onset, triggers, symptom duration, treatment received, remission date. If you have a psychiatric report, bring a full copy.
Do not omit information. Under MED.A.020, reporting any decrease in medical fitness — including anxiety episodes — is mandatory. Undisclosed history found later can lead to certificate revocation.
Frequently asked questions about pilot anxiety assessment
Does a single panic attack suspend my certificate? Not automatically. With an identifiable trigger, full recovery and a favourable AME assessment you may stay fit after a 48-hour ground trial.
Can I fly on sertraline? Yes, with OML for Class 1, after at least 4 weeks of stable dosing and a favourable psychiatric report.
How long is the return to flying? Recent studies show that more than 80% of pilots who disclose an anxiety episode return to flying within 12 months. Early disclosure and close AME cooperation are the key.
Will I be asked to fill in validated scales at the AME office? Yes. The most common in a pilot anxiety assessment are GAD-7 for generalised anxiety, PHQ-9 for comorbid depression and PCL-5 for post-traumatic stress. The scales are completed on site and attached to the file.
Is the Peer Support programme mandatory? For commercial AOC operators, yes: Regulation (EU) 2018/1042 requires a confidential peer-support programme. Discussions inside the programme are protected and are not automatically reported to the AME, but a pilot may be advised to request aeromedical review if a clear risk appears.
Common mistakes that complicate a pilot anxiety assessment
Self-medication with over-the-counter anxiolytics or “natural” products (kava, high-dose valerian, St John’s wort). All of these interfere with testing and can show up at screening. Self-medication must be reported to the AME before the examination.
Delaying disclosure of psychological counselling because “it was not treatment”. Under MED.A.020, any consultation aimed at a psychiatric diagnosis, with or without medication, falls under the reporting obligation.
Requesting a psychiatric report from a specialist without aviation experience. The report must explicitly state the conclusion about compatibility with flying, not only the diagnosis and treatment. A generic report forces the AME to ask for an additional review.
Lack of a documented ground-trial plan. For SSRI, the AME expects a short journal covering the first 4 weeks: residual symptoms, side effects, sleep quality, quick cognitive tests. Without this journal the SSRI assessment can be postponed.
Conclusion
A pilot anxiety assessment is not an automatic loss of certificate. The EASA Part-MED framework, supported by AMC/GM and the UK CAA guidance, recognises the difference between an acute stress reaction, an adjustment disorder and a true anxiety disorder. Prompt reporting, complete documentation and close AME cooperation drive a management plan compatible with active flying. For pilots who disclose episodes early, the 12-month return-to-flying rate exceeds 80% in recent aviation-psychology literature.
How LaMed Clinic helps you with anxiety assessment
An anxiety episode or an acute stress reaction can quickly become a complex file if not managed correctly from the start. At LaMed Clinic we run a complete aeromedical pathway, from the initial confidential interview to the final documentation submitted to the Romanian aeromedical authority.
Through the LaMed contact form you can request:
Confidential pre-screening of the anxiety or stress episode, with an indicative risk category (acute reaction, adjustment disorder, anxiety disorder).
Referral to a psychiatrist or clinical psychologist with aviation-psychology experience, for the specialist report required by the AME.
Support for the pilot anxiety assessment documentation — timeline, validated scales, treatment plan, ground-trial record.
Liaison with the Romanian aeromedical authority for OML/OSL limitations or for unrestricted return to flying.
All enquiries are treated confidentially. A single message through the LaMed contact page is enough to start the process.
Official sources and references
1. EASA — Regulation (EU) 1178/2011, Part-MED, MED.B.055 and MED.B.060.
2. EASA — AMC and GM to Part-MED, Initial issue (Comprehensive Mental Health Assessment).
3. UK CAA — Mental Health Guidance Material for AMEs (anxiety, panic disorder, adjustment disorder, return to flying).
4. EASA — MESAFE Project Report, Mental Health for Aviation Safety, Horizon Europe.
5. PAC-MED edition 1 (2026), Romanian aeromedical procedure.
6. EUR-Lex — consolidated Regulation (EU) 1178/2011.
Disclaimer
This material is informative and educational. It does not constitute medical advice, aeromedical evaluation or certification decision. Any change in treatment, reporting to the licensing authority or fit-to-fly decision must be made exclusively through a certified AME and, where applicable, a psychiatrist with aviation-medicine experience.
